CDK2 and cervical cancer: Furthermore, consistent with the fact that p21 is a cyclin-dependent kinase inhibitor, we found that levels of cyclin-related proteins such as Cyclin D1, Cyclin E1, CDK2 and CDK4 were reduced in cervical cancer cells overexpressed by ST3Gal IV.